Evaluation of immunogenicity after first dose of hepatitis B vaccine in newborns with very low birth weight

Basit Öğe Kaydı
dc.authorscopusid39763256900
dc.authorscopusid57188922138
dc.authorscopusid15837539300
dc.contributor.authorTüfekci, Sinan
dc.contributor.authorAygün, Erhan
dc.contributor.authorHalis, Hülya
dc.date.accessioned2022-05-11T14:05:00Z
dc.date.available2022-05-11T14:05:00Z
dc.date.issued2021
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractObjective: Hepatitis-B virus (HBV) infection is an important health problem worldwide. HBV vaccine application varies according to the birth weight and gestational week in the neonatal period. This study aimed to reconsider delaying the administration of the HBV vaccine because the birth weight of newborns was very low. Methods: The newborns with very low birth weight in the study group were babies weighing less than 2000 g in the postnatal first month and at the time of administering HBV vaccine. Babies born at term from mothers who did not receive an HBV vaccine, had negative hepatitis B surface antibody levels, and were given HBV vaccine at birth were included in the study as a control group. The antibody levels against HBV vaccine were compared between these two groups. Results: The retrospective study included 60 participants (32 men and 28 women) grouped as control first vaccine weight (first vaccine weight was >2000 g, control group, n = 30) and case vaccine weight (first vaccine weight was <2000 g, case group, n = 30). The mean birth weight was 2976 ± 84.8 g and 1054 ± 44.5 g in the control and case groups, respectively. The first vaccine weight was 2030–3780 g and 960–1900 g in the control and case groups, respectively. The mean antibody level was 297.8 ± 76.3IU/mL and 309.7 ± 56.3IU/mL in the <1500 g and >1500 g groups, respectively. No significant difference was found in hepatitis antibody levels between the groups. Conclusion: Further studies in larger samples are needed to confirm the efficacy and efficiency of postponement of hepatitis B vaccination in babies with a birth weight of <2000 g. © 2021 Taylor & Francis Group, LLC.
dc.description.sponsorshipThe authors received no financial support for the research, authorship, and/or publication of this article.
dc.identifier.doi10.1080/21645515.2021.1942715
dc.identifier.endpage5594
dc.identifier.issn2164-5515
dc.identifier.issue12en_US
dc.identifier.pmid34289333
dc.identifier.scopus2-s2.0-85111109109
dc.identifier.scopusqualityQ1
dc.identifier.startpage5590
dc.identifier.urihttps://doi.org/10.1080/21645515.2021.1942715
dc.identifier.urihttps://hdl.handle.net/20.500.11776/4861
dc.identifier.volume17
dc.identifier.wosWOS:000675356800001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTüfekci, Sinan
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofHuman Vaccines and Immunotherapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHepatitis B vaccine
dc.subjectvery low birth weight newborns
dc.titleEvaluation of immunogenicity after first dose of hepatitis B vaccine in newborns with very low birth weight
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
4861.pdf
Boyut:
559.4 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu